Global News reported that Health Canada has decided to change and expand its medical marijuana regulations, allowing the sale of oil and fresh buds in addition to the dried form of the drug.
As quoted in the market news:

The new rules announced Wednesday comes on the heels of last month’s unanimous Supreme Court of Canada decision that struck down limits on what constitutes legally allowable forms of medicinal pot.
Under the new rules 25 licensed producers across the country will be able to produce and sell cannabis oil, fresh buds and leaves needed to make edible products to registered patients. However, producers will not be permitted to sell plant material that can be used to propagate marijuana.
Health Minister Rona Ambrose had initially said she was outraged by the Supreme Court decision, which would let patients consume the drug in the form of edible brownies or cookies.
The high court ruling also left a grey area for commercially licensed pot producers as the decision gave medical marijuana users the right to both possess and consume cannabis derivatives, such as edibles, but it was unclear if licensed growers were allowed to sell anything other than the dried form of the drug.
Ambrose said in a statement Wednesday the new guidelines are intended to eliminate any confusion and reiterated the government’s stance that marijuana is not an “approved drug or medicine.”

Click here to read the full Global News report.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less